These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8193427)

  • 1. Hypertension and endstage renal disease.
    Brown TE; Carter BL
    Ann Pharmacother; 1994 Mar; 28(3):359-66. PubMed ID: 8193427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. At risk nephrons and the decline in renal function in response to treatment of hypertension.
    Walker WG; Ford C
    Trans Am Clin Climatol Assoc; 1996; 107():134-43; discussion 143-5. PubMed ID: 8725567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence.
    Whelton PK; Klag MJ
    Hypertension; 1989 May; 13(5 Suppl):I19-27. PubMed ID: 2490824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.
    Karunaratne K; Stevens P; Irving J; Hobbs H; Kilbride H; Kingston R; Farmer C
    Nephrol Dial Transplant; 2013 Aug; 28(8):2107-16. PubMed ID: 23658247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.
    He J; Whelton PK
    J Hypertens Suppl; 1999 Jun; 17(2):S7-13. PubMed ID: 10465061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Challenges of Blood Pressure Control in Dialysis Patients.
    Campese VM; Lakdawala R
    Recent Adv Cardiovasc Drug Discov; 2015; 10(1):34-59. PubMed ID: 26567722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of antihypertensive treatment on kidney function in insulin-dependent (type I) diabetics with renal failure.
    Zander E; Conde N; Heinke P; Zander G; Strese J; Gums G; Schulz B
    Exp Clin Endocrinol; 1990 Feb; 95(1):70-6. PubMed ID: 2335182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension as a risk factor for progression of chronic renal disease.
    Epstein M
    Blood Press Suppl; 1994; 1():23-8. PubMed ID: 8205294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
    Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.
    Hsu CY; McCulloch CE; Darbinian J; Go AS; Iribarren C
    Arch Intern Med; 2005 Apr; 165(8):923-8. PubMed ID: 15851645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which antihypertensive drugs are the most nephroprotective and why?
    Cravedi P; Ruggenenti P; Remuzzi G
    Expert Opin Pharmacother; 2010 Nov; 11(16):2651-63. PubMed ID: 20977400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease.
    Ku E; Glidden DV; Johansen KL; Sarnak M; Tighiouart H; Grimes B; Hsu CY
    Kidney Int; 2015 May; 87(5):1055-60. PubMed ID: 25493952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
    Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
    Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.